149 related articles for article (PubMed ID: 36708218)
21. Cellular localization of the cell cycle inhibitor Cdkn1c controls growth arrest of adult skeletal muscle stem cells.
Mademtzoglou D; Asakura Y; Borok MJ; Alonso-Martin S; Mourikis P; Kodaka Y; Mohan A; Asakura A; Relaix F
Elife; 2018 Oct; 7():. PubMed ID: 30284969
[TBL] [Abstract][Full Text] [Related]
22. CDKN1C-mediated growth inhibition by an EZH1/2 dual inhibitor overcomes resistance of mantle cell lymphoma to ibrutinib.
Kagiyama Y; Fujita S; Shima Y; Yamagata K; Katsumoto T; Nakagawa M; Honma D; Adachi N; Araki K; Kato A; Inaki K; Ono Y; Fukuhara S; Kobayashi Y; Tobinai K; Kitabayashi I
Cancer Sci; 2021 Jun; 112(6):2314-2324. PubMed ID: 33792119
[TBL] [Abstract][Full Text] [Related]
23. The developmental expression of the CDK inhibitor p57(kip2) (Cdkn1c) in the early mouse placenta.
Saunders AC; McGonnigal B; Uzun A; Padbury J
Mol Reprod Dev; 2016 May; 83(5):405-12. PubMed ID: 26988311
[TBL] [Abstract][Full Text] [Related]
24. Long non-coding RNA SNHG17 is an unfavourable prognostic factor and promotes cell proliferation by epigenetically silencing P57 in colorectal cancer.
Ma Z; Gu S; Song M; Yan C; Hui B; Ji H; Wang J; Zhang J; Wang K; Zhao Q
Mol Biosyst; 2017 Oct; 13(11):2350-2361. PubMed ID: 28933484
[TBL] [Abstract][Full Text] [Related]
25. L-carnosine induces apoptosis/cell cycle arrest via suppression of NF-κB/STAT1 pathway in HCT116 colorectal cancer cells.
Lee J; Park JR; Lee H; Jang S; Ryu SM; Kim H; Kim D; Jang A; Yang SR
In Vitro Cell Dev Biol Anim; 2018 Aug; 54(7):505-512. PubMed ID: 29869056
[TBL] [Abstract][Full Text] [Related]
26. Genetic and Epigenetic Control of CDKN1C Expression: Importance in Cell Commitment and Differentiation, Tissue Homeostasis and Human Diseases.
Stampone E; Caldarelli I; Zullo A; Bencivenga D; Mancini FP; Della Ragione F; Borriello A
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29614816
[TBL] [Abstract][Full Text] [Related]
27. Knockdown of REG Iα Enhances the Sensitivity to 5-Fluorouracil of Colorectal Cancer Cells via Cyclin D1/CDK4 Pathway and BAX/BCL-2 Pathways.
Wang Y; Liu X; Liu J; Zhang T
Cancer Biother Radiopharm; 2019 Aug; 34(6):362-370. PubMed ID: 30973271
[No Abstract] [Full Text] [Related]
28. Cyclin D1 degradation and p21 induction contribute to growth inhibition of colorectal cancer cells induced by epigallocatechin-3-gallate.
Zhang X; Min KW; Wimalasena J; Baek SJ
J Cancer Res Clin Oncol; 2012 Dec; 138(12):2051-60. PubMed ID: 22814742
[TBL] [Abstract][Full Text] [Related]
29. The cell cycle-regulated B-Myb transcription factor overcomes cyclin-dependent kinase inhibitory activity of p57(KIP2) by interacting with its cyclin-binding domain.
Joaquin M; Watson RJ
J Biol Chem; 2003 Nov; 278(45):44255-64. PubMed ID: 12947099
[TBL] [Abstract][Full Text] [Related]
30. p57(Kip2) knock-in mouse reveals CDK-independent contribution in the development of Beckwith-Wiedemann syndrome.
Duquesnes N; Callot C; Jeannot P; Daburon V; Nakayama KI; Manenti S; Davy A; Besson A
J Pathol; 2016 Jul; 239(3):250-61. PubMed ID: 27015986
[TBL] [Abstract][Full Text] [Related]
31. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
32. Multiple mechanisms downregulate CDKN1C in human bladder cancer.
Hoffmann MJ; Florl AR; Seifert HH; Schulz WA
Int J Cancer; 2005 Apr; 114(3):406-13. PubMed ID: 15551363
[TBL] [Abstract][Full Text] [Related]
33. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
[TBL] [Abstract][Full Text] [Related]
34. p57Kip2 is a downstream effector of BCR-ABL kinase inhibitors in chronic myelogenous leukemia cells.
Borriello A; Caldarelli I; Bencivenga D; Cucciolla V; Oliva A; Usala E; Danise P; Ronzoni L; Perrotta S; Della Ragione F
Carcinogenesis; 2011 Jan; 32(1):10-8. PubMed ID: 20952511
[TBL] [Abstract][Full Text] [Related]
35. Transforming growth factor beta-induced cell cycle arrest of human hematopoietic cells requires p57KIP2 up-regulation.
Scandura JM; Boccuni P; Massagué J; Nimer SD
Proc Natl Acad Sci U S A; 2004 Oct; 101(42):15231-6. PubMed ID: 15477587
[TBL] [Abstract][Full Text] [Related]
36. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
[TBL] [Abstract][Full Text] [Related]
37. gamma-Linolenic acid blocks cell cycle progression by regulating phosphorylation of p27kip1 and p57kip2 and their interactions with other cycle regulators in cancer cells.
Jiang WG; Bryce RP; Horrobin DF; Mansel RE
Int J Oncol; 1998 Sep; 13(3):611-7. PubMed ID: 9683802
[TBL] [Abstract][Full Text] [Related]
38. C/EBPbeta Promotes transition from proliferation to hypertrophic differentiation of chondrocytes through transactivation of p57.
Hirata M; Kugimiya F; Fukai A; Ohba S; Kawamura N; Ogasawara T; Kawasaki Y; Saito T; Yano F; Ikeda T; Nakamura K; Chung UI; Kawaguchi H
PLoS One; 2009; 4(2):e4543. PubMed ID: 19229324
[TBL] [Abstract][Full Text] [Related]
39. Downregulated CDKN1C/p57
Qiu Z; Li Y; Zeng B; Guan X; Li H
Biochem Biophys Res Commun; 2018 Feb; 497(1):187-193. PubMed ID: 29428729
[TBL] [Abstract][Full Text] [Related]
40. Quinalizarin Induces Apoptosis through Reactive Oxygen Species (ROS)-Mediated Mitogen-Activated Protein Kinase (MAPK) and Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathways in Colorectal Cancer Cells.
Meng LQ; Wang Y; Luo YH; Piao XJ; Liu C; Wang Y; Zhang Y; Wang JR; Wang H; Xu WT; Liu Y; Wu YQ; Sun HN; Han YH; Jin MH; Shen GN; Fang NZ; Jin CH
Med Sci Monit; 2018 Jun; 24():3710-3719. PubMed ID: 29860266
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
